MiR-34a and miR-206 act as novel prognostic and therapy biomarkers in cervical cancer
Abstract Background Recent evidence indicated that the aberrant expression of microRNA plays a crucial role in the development of cervical cancer. The overall shorter survival was strongly related to the abnormal expression of microRNA-34a (miR-34a) and microRNA-206 (miR-206), which target B cell ly...
Furkejuvvon:
| Váldodahkkit: | , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
BMC
2017-06-01
|
| Ráidu: | Cancer Cell International |
| Fáttát: | |
| Liŋkkat: | http://link.springer.com/article/10.1186/s12935-017-0431-9 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|